(NP (NP (NP (JJ TAR-independent) (NN transactivation)) (PP (IN by) (NP (NN Tat))) (PP (IN in) (NP (NP (NNS cells)) (VP (VBN derived) (NP (-NONE- *)) (PP (IN from) (NP (DT the) (NN CNS)))))) (: :)) (NP (NP (DT a) (JJ novel) (NN mechanism)) (PP (IN of) (NP (NN HIV-1) (NN gene) (NN regulation))) (. .)))
(S (NP-SBJ (NP (DT The) (NN Tat) (NN protein)) (PP (IN of) (NP (NP (JJ human) (NN immunodeficiency) (NN virus) (NN type) (CD 1)) (PRN (-LRB- -LRB-) (NP (NN HIV-1)) (-RRB- -RRB-))))) (VP-COOD (VP (VBZ is) (ADJP-PRD (JJ essential) (PP (IN for) (NP (JJ productive) (NN infection))))) (CC and) (VP (VBZ is) (NP-PRD (NP (DT a) (JJ potential) (NN target)) (PP (IN for) (NP (JJ antiviral) (NN therapy)))))) (. .))
(S (NP-SBJ-16 (NP (NN Tat)) (, ,) (NP (NP (DT a) (JJ potent) (NN activator)) (PP (IN of) (NP (NN HIV-1) (NN gene) (NN expression)))) (, ,)) (VP (VBZ serves) (S (NP-SBJ (-NONE- *-16)) (VP (TO to) (ADVP (RB greatly)) (VP (VB increase) (NP (NP (DT the) (NN rate)) (PP (IN of) (NP (NP (NN transcription)) (VP (VBN directed) (NP (-NONE- *)) (PP (IN by) (NP-LGS (DT the) (JJ viral) (NN promoter))))))))))) (. .))
(S (NP-SBJ (NP (DT This) (NN induction)) (, ,) (SBAR (WHNP-17 (WDT which)) (S (NP-SBJ-18 (-NONE- *T*-17)) (VP (VBZ seems) (S (NP-SBJ (-NONE- *-18)) (VP (TO to) (VP (VB be) (NP-PRD (NP (DT an) (JJ important) (NN component)) (PP (IN in) (NP (NP (DT the) (NN progression)) (PP (IN of) (NP (NP (VBN acquired) (JJ immune) (NN deficiency) (NN syndrome)) (PRN (-LRB- -LRB-) (NP (NN AIDS)) (-RRB- -RRB-))))))))))))) (, ,)) (VP (MD may) (VP (VB be) (PP-PRD (JJ due) (TO to) (NP-COOD (NP (VBN increased) (JJ transcriptional) (NN initiation)) (, ,) (NP (VBN increased) (JJ transcriptional) (NN elongation)) (, ,) (CC or) (NP (NP (DT a) (NN combination)) (PP (IN of) (NP (DT these) (NNS processes)))))))) (. .))
(S (NP-SBJ-19 (JJ Much) (NN attention)) (VP (VBZ has) (VP (VBN been) (VP (VBN focused) (NP (-NONE- *-19)) (PP (IN on) (NP (NP (DT the) (NN interaction)) (PP (IN of) (NP (NN Tat))) (PP (IN with) (NP (NP (DT a) (JJ specific) (NN RNA) (NN target)) (VP (VBN termed) (S (NP-SBJ (-NONE- *)) (NP-PRD (NP (NN TAR)) (PRN (-LRB- -LRB-) (NP (NN transactivation) (NN responsive)) (-RRB- -RRB-))))) (SBAR (WHNP-20 (WDT which)) (S (NP-SBJ (-NONE- *T*-20)) (VP (VBZ is) (ADJP-PRD (JJ present) (PP (IN in) (NP (NP (DT the) (NN leader) (NN sequence)) (PP (IN of) (NP (DT all) (NN HIV-1) (NNS mRNAs)))))))))))))))) (. .))
(S (NP-SBJ-21 (DT This) (NN interaction)) (VP (VBZ is) (VP (VBN believed) (S (NP-SBJ (-NONE- *-21)) (VP (TO to) (VP (VB be) (NP-PRD (NP (DT an) (JJ important) (NN component)) (PP (IN of) (NP (NP (DT the) (NN mechanism)) (PP (IN of) (NP (NN transactivation))))))))))) (. .))
(S (PP (IN In) (NP (DT this) (NN report))) (NP-SBJ (PRP we)) (VP (VBP demonstrate) (SBAR (IN that) (S (PP (IN in) (NP (JJ certain) (JJ CNS-derived) (NNS cells))) (NP-SBJ-22 (NN Tat)) (VP (VBZ is) (ADJP-PRD (JJ capable) (PP (IN of) (S (NP-SBJ (-NONE- *-22)) (VP (VBG activating) (NP (NN HIV-1)) (PP (IN through) (NP (DT a) (JJ TAR-independent) (NN pathway))))))))))) (. .))
(S (NP-SBJ-23 (DT A) (JJ Tat-responsive) (NN element)) (VP (VBZ is) (VP (VBN found) (S (NP-SBJ (-NONE- *-23)) (ADVP-PRD (RB upstream) (PP (IN within) (NP (NP (DT the) (JJ viral) (NN promoter)) (SBAR (WHNP-24 (WDT that)) (S (PP (IN in) (NP (JJ glial-derived) (NN cell) (NNS lines))) (NP-SBJ (-NONE- *T*-24)) (VP (VBZ allows) (NP (NN transactivation)) (PP (IN in) (DT the) (NN absence) (IN of) (NP (NN TAR)))))))))))) (. .))
(S (NP-SBJ-COOD (NP (NN Deletion) (NN mapping)) (CC and) (NP (NN hybrid) (NN promoter) (NNS constructs))) (VP (VBP demonstrate) (SBAR (IN that) (S (NP-SBJ (DT the) (ADJP (RB newly) (VBN identified)) (JJ Tat-responsive) (NN element)) (VP (VBZ corresponds) (PP (TO to) (NP (NP (DT a) (NN sequence)) (PP (IN within) (NP (DT the) (JJ viral) (NP (NP (JJ long) (JJ terminal) (NN repeat)) (PRN (-LRB- -LRB-) (NP (NN LTR)) (-RRB- -RRB-))))) (VP (ADVP-TMP (RB previously)) (VBN identified) (NP (-NONE- *)) (PP (IN as) (NP (NP (DT the) (NN HIV-1) (NN enhancer)) (, ,) (CC or) (NP (NN NF-kappa) (NN B) (NN domain))))))))))) (. .))
(S (NP-SBJ (NN DNA) (JJ band-shift) (NN analysis)) (VP (VBZ reveals) (NP (NP (NN NF-kappa) (NN B) (NN binding) (NN activity)) (PP (IN in) (NP (JJ glial) (NNS cells))) (SBAR (WHNP-25 (WDT that)) (S (NP-SBJ (-NONE- *T*-25)) (VP (VBZ differs) (PP (IN from) (NP (NP (DT that)) (ADJP (JJ present) (PP (IN in) (NP (NN T) (JJ lymphoid) (NNS cells))))))))))) (. .))
(S (ADVP (RB Further)) (, ,) (NP-SBJ (PRP we)) (VP (VBP observe) (SBAR (IN that) (S (NP-SBJ (NP (JJ TAR-deleted) (NNS mutants)) (PP (IN of) (NP (NN HIV-1)))) (VP (VBP demonstrate) (NP (NP (JJ normal) (JJ late) (NN gene) (NN expression)) (PP (IN in) (NP (JJ glial) (NNS cells)))) (SBAR (IN as) (S (NP-SBJ-26 (-NONE- *)) (VP (VBN evidenced) (NP (-NONE- *-26)) (PP (IN by) (NP-LGS (NP (NN syncytia) (NP-COOD (NP (NN formation)) (CC and) (NP (NN production)))) (PP (IN of) (NP (JJ viral) (NN p24) (NN antigen)))))))))))) (. .))
(S (-LRB- -LRB-) (NP-SBJ-100 (NN ABSTRACT)) (VP (VBN TRUNCATED) (NP (-NONE- *-100)) (PP (IN AT) (NP (CD 250) (NNS WORDS)))) (-RRB- -RRB-))
